BMJ10d
What are the lived healthcare experiences of patients with primary sclerosing cholangitis? A community-based qualitative interview study
Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and ...
News Medical on MSN2d
Oral vancomycin induces PSC-IBD remission, driving gut microbiome and metabolic shifts
In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces ...
Common antibiotic for diarrhoea shows hope for inflammatory bowel disease: Study
The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...
WBBJ-TV8d
Former athlete shares her experience with rare liver disease
Rare Disease Day is February 28. Primary sclerosing cholangitis or PSC is a rare liver disease characterized by progressive ...
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues
Pliant Therapeutics, Inc. (NASDAQ:PLRX) stock is trading lower on Monday. On Friday, during after-hours trading, Pliant ...
technologynetworks4d
Antibiotic Shows Promise for Treating Inflammatory Bowel Disease
Results published in the Journal of Crohn's and Colitis revealed that an antibiotic called vancomycin may also be effective ...
mp.pl10d
Immunoglobulin A antibodies: prognostic tools with unknown mechanism in primary sclerosing cholangitis
We read with great interest the study by Wunsch et al 1 published in this issue of Polish Archives of Internal Medicine, which validated the prognostic ability of 2 previously ide ...
Common antibiotic that treats diarrhea can also treat inflammatory bowel disease: Study
A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively ...
Canaccord Genuity cuts Pliant to hold on study setback
Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...